Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer

ATASOY, BESTE; ABACIOGLU, MEHMET; Dane, F.; Ozgen, Z.; Yumuk, P.; Ozden, S.; Akgun, Z.; Mayadagli, A.; BAŞARAN, GÜL; Turhal, S.; Sengoz, M.

Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer

ATASOY B. M., ABACIOGLU M. U., Dane F., Ozgen Z., Yumuk P. F., Ozden S., ...Daha Fazla

JOURNAL OF BUON, cilt.12, sa.2, ss.203-208, 2007 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 12 Sayı: 2
Basım Tarihi: 2007
Dergi Adı: JOURNAL OF BUON
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.203-208
Anahtar Kelimeler: concomitant chemoradiotherapy, oral fluoropyrimidine, rectal cancer, survival, toxicity, UFT, ORAL LEUCOVORIN, PHASE-III, FLUOROURACIL, CHEMOTHERAPY, THERAPY, UFT, MULTICENTER, TRIAL
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Purpose: We report the feasibility and toxicity profile, and the impact on local control, disease-free survival and overall survival rates of our study which consisted of postoperative concurrent chemoradiotherapy, followed by adjuvant chemotherapy using uracil-tegafur (UFT)/leukovorin (L V) in locally advanced rectal cancer patients.